| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Gregory Grunberg last filed a Form 4 in June 2021, as Director at KALA. Gregory Grunberg's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 40,000 shares of KALA. Net of sales, the KALA filings show accumulation of 3,355,914 shares.
Gregory Grunberg has 8 Form 4 filings on record from July 2017 to June 2021, all as Director at Kala Bio (KALA), 2017–2021.
The 9 reported transactions were 3 open-market purchases, 3 option or other derivative awards, 2 stock awards and 1 conversion.
Counted by filing, the open-market trades come to 3 purchases worth about $28.2M and no sales.
The largest open-market purchase was 2,534,854 shares of KALA at an average $7.89 on March 13, 2020, about $20.0M.
Shares as reported in the last Form 4 for each company; the most recent is from June 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.